Chemical Compound

(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E

CAS Registry Number 86639-52-3
(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E 结构式
Primary record

(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E

库存
2,578 克
纯度
99.3 %
CAS
86639-52-3

化合物标识与属性

CAS
86639-52-3
PubChem CID
104842
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
Canonical SMILES
CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC

名称与同义词

  • 7-Ethyl-10-hydroxycamptothecin
  • SN-38
  • 86639-52-3
  • SN 38 lactone
  • SN 38
  • Camptothecin analog
  • Deruxtecan analog
  • 7-Ethyl-10-hydroxy-camptothecin
  • 10-Hydroxy-7-ethylcamptothecin
  • EHCPT
  • HCPT
  • Irinotecan related compound b
  • SN38
  • AvaChem1025
  • SN-38 (Standard)
  • LE-SN38
  • MFCD00871873
  • NK-012
  • AC1L2XLK
  • RefChem:914300
  • 7-10-hydroxycamptothecin
  • NK012
  • NK 012
  • 7-Ethyl-10-hydroxycamptothecine
  • CHEMBL837
  • D0B6YB
  • D0L5LG
  • diethyl(dihydroxy)[?]dione
  • 7-Ethyl-10-hydroxy-20(S)-camptothecin
  • CHEBI:8988
  • C22H20N2O5
  • SCHEMBL34018
  • Captothecin, 7-ethyl-10-hydroxy-
  • DTXSID4040399
  • UNII-0H43101T0J
  • 7-Ethyl-10-hydroxy camptothecin
  • CHEMBL93068
  • FJHBVJOVLFPMQE-QFIPXVFZSA-N
  • GTPL6925
  • orb1307686
  • SN 38 [WHO-DD]
  • SN-38L
  • (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 7 Ethyl 10 hydroxycamptothecin
  • 0H43101T0J
  • DTXCID2020399
  • SCHEMBL29354078
  • SCHEMBL29359781
  • SN-38-d3
  • 10-hydroxy-7-ethyl camptothecin
  • 10-hydroxy-7-ethyl-camptothecin
  • KS-00000NHR
  • 7-Ethyl-10-hydroxy campthotecin
  • EX-A989
  • IT-141
  • NSC673596
  • BADC-01393
  • HMS3413B12
  • HMS3652P12
  • HMS3677B12
  • HMS3753E15
  • AOB33769
  • BCP01386
  • ZINC4099013
  • 7-Ethyl-10-hydroxy-20(S)-CPT
  • CAMPTOTHECIN, 7-ETHYL-10-HYDROXY-
  • (R)-SN-38
  • BDBM50418088
  • CE-042
  • CID104842
  • EBC-11025
  • HY-13704R
  • Irinotecan EP Impurity E (SN-38)
  • MSK162382
  • s4908
  • AKOS015920433
  • C22-H20-N2-O5
  • AC-1357
  • ACN-035263
  • ACN-054099
  • AN-5834
  • BCP9000200
  • CB10641
  • CCG-264764
  • CS-1579
  • CS-O-30862
  • DB05482
  • FE29579
  • LS00055
  • NSC-673596
  • RL05364
  • SN-38(NK-012)?
  • (+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN
  • NCGC00167831-01
  • NCGC00167831-05
  • SN-38(7-Ethyl-10-hydroxycamptothecin)
  • AJ-48031
  • AK-36613
  • AS-13533
  • BC206169
  • BP-24513
  • BR-36613
  • Camptothecin 7-Ethyl-10-Hydroxy Impurity
  • HY-13704
  • I605
  • NCI60_026056
  • SC-15667
  • SY013197
  • 7-Ethyl-10-Hydroxycamptothecin, food grade
  • AB0013784
  • J353.490A
  • LS-127394
  • TL8005626
  • E0748
  • FT-0630943
  • FT-0674607
  • FT-0674608
  • N2133
  • NS00069821
  • SW219948-1
  • S-(+)-7-ETHYL-10-HYDROXYCAMPOTHECIN
  • A12011
  • C11173
  • EN300-122379
  • IRINOTECAN RELATED COMPOUND B [USP-RS]
  • J90015
  • S-5119
  • (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
  • 439E812
  • A857464
  • F046379
  • 113015-38-6
  • A1010140
  • Q1750127
  • 50P114089
  • BRD-K89561498-001-01-7
  • BRD-K89561498-001-02-5
  • (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • (4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 7-Ethyl-10-hydroxycamptothecin, >=98% (HPLC), powder
  • 7-Ethyl-10-hydroxycamptothecin, 99% - 100MG 100mg
  • Z1541759909
  • (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione
  • Irinotecan EP Impurity E; Camptothecin 7-Ethyl-10-Hydroxy Impurity
  • (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (1S,2S,3R)-1-(3,4-dihydroxy-5-methoxy-phenyl)-2,3,7-trihydroxy-3-(hydroxymethyl)-6-methoxy-tetralin-2-carboxylic acid
  • 110714-48-2
  • 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4,9-DIHYDROXY-, (4S)-
  • H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (S)-
  • Irinotecan Related Compound B, United States Pharmacopeia (USP) Reference Standard
  • (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, AldrichCPR
  • (4S)-4,11-Diethyl-4,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4,9-Dihydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4,9-Dihydroxy-4alpha,11-diethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4beta,9-Dihydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4beta,9-Dihydroxy-4,11-diethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-9-Hydroxy-4-hydroxy-4,11-diethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (5S)-3,2-(6-Hydroxy-4-ethylquinoline-2,3-diylmethylene)-5-hydroxy-5-ethyl-1,6(2H,8H)-dioxo-7-oxaisoquinoline
  • (5S)-3,2-(6-Hydroxy-4-ethylquinoline-2,3-diylmethylene)-5alpha-hydroxy-5-ethyl-1,6(2H,8H)-dioxo-7-oxaisoquinoline
  • (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4,11-diethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
  • (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl-10-hydroxy-20(S)-camptothecin; 7-Ethyl-10-hydroxycamptothecin; (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 11-Ethyl-9-hydroxycamptothecin; Irinotecan Related Compound B; Irinotecan Hydrochloride Trihydrate Impurity E; Irinotecan Impurity E
  • 119577-28-5
  • 130144-34-2
  • 130194-92-2
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,7-diethyl-4,10-dihydroxy-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-
  • 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-
  • 64439-81-2
  • 647852-82-2
  • 7-Ethyl-10-hydroxycamptothecin ((S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
  • 718612-49-8
  • EHC
  • RS4